GlassScriptPhysician profile
Chynna M Hatcher
NPI 1598212300
$1,761.94
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $383 · 2022: $1,252 · 2023: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $617.84 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $100.82 | 2022 | |
| Novartis Pharmaceuticals Corporation | $96.62 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $93.26 | 2021-2022 | |
| Redhill Biopharma INC. | $91.48 | 2021 | |
| Merck Sharp & Dohme LLC | $91.33 | 2022-2023 | Verquvo, Belsomra |
| Amarin Pharma, INC. | $87.03 | 2021 | |
| Abbott Laboratories | $84.52 | 2022-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $81.70 | 2021-2022 | |
| Glaxosmithkline, LLC. | $78.32 | 2021-2022 | |
| Abbvie INC. | $76.11 | 2021-2023 | |
| Lilly USA, LLC | $61.08 | 2021-2022 | |
| Pfizer INC. | $46.60 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.04 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $34.33 | 2022-2023 | Xarelto |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $19.08 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.23 | 2022 | |
| Dexcom, INC. | $16.52 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.98 | 2022 | |
| Mylan Specialty L.P. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chynna Hatcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.